![Sushil Patel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sushil Patel
Chief Executive Officer at
REPLIMUNE GROUP, INC.
Net worth: 10 M $ as of 2026-05-30
Profile
Sushil Patel is currently Chief Executive Officer & Director at Replimune Group, Inc. since 2024 and Independent Director at Revolution Medicines, Inc. since 2022.
Formerly, Dr. Patel was Vice President-Franchise & Head-Oncology at Genentech, Inc. from 2018 to 2021.
Education includes an undergraduate degree from the University of Warwick in 1992, a graduate degree from Imperial College London in 1993, and a doctorate from the University of London in 1999.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-17 | 747,492 ( 0.96% ) | 6 M $ | 2026-05-30 | |
| 2026-06-28 | 21,656 ( 0.01% ) | 3 M $ | 2026-05-30 |
Sushil Patel active positions
| Companies | Position | Start |
|---|---|---|
| REPLIMUNE GROUP, INC. | Chief Executive Officer | 2024-03-31 |
| REVOLUTION MEDICINES, INC. | Director/Board Member | 2022-06-15 |
Former positions of Sushil Patel
| Companies | Position | End |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 2021-04-30 |
Training of Sushil Patel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
95
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Warwick
 University of Warwick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Revolution Medicines, Inc.
 Revolution Medicines, Inc. Pharmaceuticals: OtherHealth Technology Develops new therapies derived from natural products | Health Technology |
Replimune Group, Inc.
 Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
- Stock Market
- Insiders
- Sushil Patel
